CT Psy Med: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CT Psy Med
Largest movements
- Receivables within one year -€17,790
down €17,790 (-21.3%), from €83,444 to €65,654
of which Other amounts receivable: -€12,287
- Cash -€13,006
down €13,006 (-93.5%), from €13,912 to €907
mainly Other debts (-€30,700) and Contributions, distributions and other (-€26,000)
- Tangible fixed assets -€5,026
down €5,026 (-24.4%), from €20,563 to €15,536
of which Furniture and vehicles: -€4,719
- Deferred charges and accrued income -€1,458
down €1,458 (-35.7%), from €4,078 to €2,621
- Other debts -€30,700
down €30,700 (-54.1%), from €56,700 to €26,000
- Tax, wage and social debts -€6,609
down €6,609 (-15.3%), from €43,270 to €36,661
- Gross operating margin -€40,854
down €40,854 (-50.7%), from €80,523 to €39,669
- Taxes -€11,267
down €11,267 (-47.0%), from €23,964 to €12,697
- Depreciation +€2,815
up €2,815 (+127%), from €2,211 to €5,026
- Financial income +€1,291
up €1,291 (+33.6%), from €3,839 to €5,130
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €121,997 | €84,717 | -€37,280 | -30.6% |
| Fixed assets | 21/28 | €20,563 | €15,536 | -€5,026 | -24.4% |
| Tangible fixed assets | 22/27 | €20,563 | €15,536 | -€5,026 | -24.4% |
| Plant, machinery and equipment | 23 | €389 | €255 | -€133 | -34.3% |
| Furniture and vehicles | 24 | €18,970 | €14,252 | -€4,719 | -24.9% |
| Other tangible fixed assets | 26 | €1,203 | €1,029 | -€174 | -14.5% |
| Current assets | 29/58 | €101,435 | €69,181 | -€32,254 | -31.8% |
| Amounts receivable within one year | 40/41 | €83,444 | €65,654 | -€17,790 | -21.3% |
| Trade receivables | 40 | €8,057 | €2,554 | -€5,503 | -68.3% |
| Other amounts receivable | 41 | €75,387 | €63,100 | -€12,287 | -16.3% |
| Cash at bank and in hand | 54/58 | €13,912 | €907 | -€13,006 | -93.5% |
| Deferred charges and accrued income | 490/1 | €4,078 | €2,621 | -€1,458 | -35.7% |
| Total equity and liabilities | 10/49 | €121,997 | €84,717 | -€37,280 | -30.6% |
| Equity | 10/15 | €19,305 | €18,985 | -€320 | -1.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €705 | €385 | -€320 | -45.4% |
| Distributable reserves | 133 | €705 | €385 | -€320 | -45.4% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €102,693 | €65,732 | -€36,960 | -36.0% |
| Amounts payable within one year | 42/48 | €102,693 | €65,732 | -€36,960 | -36.0% |
| Trade debts | 44 | €2,723 | €3,072 | +€349 | +12.8% |
| Suppliers | 440/4 | €2,723 | €3,072 | +€349 | +12.8% |
| Taxes, remuneration and social security | 45 | €43,270 | €36,661 | -€6,609 | -15.3% |
| Taxes | 450/3 | €43,270 | €36,661 | -€6,609 | -15.3% |
| Other amounts payable | 47/48 | €56,700 | €26,000 | -€30,700 | -54.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,211 | €5,026 | +€2,815 | +127% |
| Other operating charges | 640/8 | €374 | €457 | +€83 | +22.1% |
| Gross operating margin | 9900 | €80,523 | €39,669 | -€40,854 | -50.7% |
| Operating profit (loss) | 9901 | €77,938 | €34,186 | -€43,752 | -56.1% |
| Financial income | 75/76B | €3,839 | €5,130 | +€1,291 | +33.6% |
| Recurring financial income | 75 | €3,839 | €5,130 | +€1,291 | +33.6% |
| Financial charges | 65/66B | €1,017 | €939 | -€77 | -7.6% |
| Recurring financial charges | 65 | €1,017 | €939 | -€77 | -7.6% |
| Profit (loss) for the period before taxes | 9903 | €80,760 | €38,377 | -€42,383 | -52.5% |
| Income taxes | 67/77 | €23,964 | €12,697 | -€11,267 | -47.0% |
| Profit (loss) for the period | 9904 | €56,796 | €25,680 | -€31,116 | -54.8% |
| Profit (loss) for the period to be appropriated | 9905 | €56,796 | €25,680 | -€31,116 | -54.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.